The role of epithelial cells in the immunopathogenesis of Sjögren's syndrome
- 3 May 2023
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 115 (1) , 57-67
Abstract
Sjögren's syndrome is a systemic autoimmune disease characterized by dysfunction of the affected exocrine glands. Lymphocytic infiltration within the inflamed glands and aberrant B-cell hyperactivation are the two salient pathologic features in Sjögren's syndrome. Increasing evidence indicates that salivary gland epithelial cells act as a key regulator in the pathogenesis of Sjögren's syndrome, as revealed by the dysregulated innate immune signaling pathways in salivary gland epithelium and increased expression of various proinflammatory molecules as well as their interaction with immune cells. In addition, salivary gland epithelial cells can regulate adaptive immune responses as nonprofessional antigen-presenting cells and promote the activation and differentiation of infiltrated immune cells. Moreover, the local inflammatory milieu can modulate the survival of salivary gland epithelial cells, leading to enhanced apoptosis and pyroptosis with the release of intracellular autoantigens, which further contributes to SG autoimmune inflammation and tissue destruction in Sjögren's syndrome. Herein, we reviewed recent advances in elucidating the role of salivary gland epithelial cells in the pathogenesis of Sjögren's syndrome, which may provide rationales for potential therapeutic targeting of salivary gland epithelial cells to alleviate salivary gland dysfunction alongside treatments with immunosuppressive reagents in Sjögren's syndrome.Keywords
This publication has 125 references indexed in Scilit:
- Interferons in Sjögren’s Syndrome: Genes, Mechanisms, and EffectsFrontiers in Immunology, 2013
- Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endotheliumAmerican Journal of Physiology-Cell Physiology, 2012
- Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren's syndromeClinical and Experimental Immunology, 2012
- Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren’s syndrome‐like diseaseOral Diseases, 2011
- Cytokines in Sjögren's syndrome: potential therapeutic targetsAnnals of the Rheumatic Diseases, 2010
- Disruption of tight junction structure in salivary glands from Sjögren's syndrome patients is linked to proinflammatory cytokine exposureArthritis & Rheumatism, 2010
- Pyroptosis: host cell death and inflammationNature Reviews Microbiology, 2009
- The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cellsJournal of Experimental Medicine, 2009
- Activation of innate immune responses through Toll‐like receptor 3 causes a rapid loss of salivary gland functionJournal of Oral Pathology & Medicine, 2008
- Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndromeClinical and Experimental Immunology, 2007